Investigational Drug Information for AZD9833
✉ Email this page to a colleague
What is the drug development status for AZD9833?
AZD9833 is an investigational drug.
There have been 15 clinical trials for AZD9833.
The most recent clinical trial was a Phase 1 trial, which was initiated on June 30th 2021.
The most common disease conditions in clinical trials are Breast Neoplasms, Liver Diseases, and Disease Progression. The leading clinical trial sponsors are AstraZeneca, Quotient Sciences, and Parexel.
There are two US patents protecting this investigational drug and fifty-two international patents.
Summary for AZD9833
| US Patents | 2 |
| International Patents | 52 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 9 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2021-06-30) |
| Vendors | 30 |
Recent Clinical Trials for AZD9833
| Title | Sponsor | Phase |
|---|---|---|
| A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors | AstraZeneca | Phase 1/Phase 2 |
| An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) | Austrian Breast and Colorectal Cancer Study Group (ABCSG) | Phase 3 |
| An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) | AstraZeneca | Phase 3 |
Clinical Trial Summary for AZD9833
Top disease conditions for AZD9833
Top clinical trial sponsors for AZD9833
US Patents for AZD9833
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| AZD9833 | ⤷ Sign Up | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Sign Up |
| AZD9833 | ⤷ Sign Up | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AZD9833
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| AZD9833 | Argentina | AR109951 | 2036-10-24 | ⤷ Sign Up |
| AZD9833 | Australia | AU2017349797 | 2036-10-24 | ⤷ Sign Up |
| AZD9833 | Brazil | BR112019007393 | 2036-10-24 | ⤷ Sign Up |
| AZD9833 | Canada | CA3040040 | 2036-10-24 | ⤷ Sign Up |
| AZD9833 | Chile | CL2019001077 | 2036-10-24 | ⤷ Sign Up |
| AZD9833 | China | CN109843888 | 2036-10-24 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
